In early January of 2024, the biotechnology research company Qvinâ„¢ made history; the FDA clearance of its Q-Padâ„¢ and A1c Test marked the first FDA approval for menstrual blood health testing.
Researchers developed a wearable pad that detects inflammation and cancer biomarkers in menstrual blood using smartphone analysis, enabling low-cost, non-invasive health monitoring at home. (Nanowerk ...
Periods are a natural part of life for millions of people, but the products we use to manage them often come with an environmental cost. Most single-use pads and tampons contain plastic, and when you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results